334 related articles for article (PubMed ID: 23972508)
1. Nevus anemicus in neurofibromatosis type 1: a potential new diagnostic criterion.
Marque M; Roubertie A; Jaussent A; Carneiro M; Meunier L; Guillot B; Pinson L; Pinson S; Bessis D
J Am Acad Dermatol; 2013 Nov; 69(5):768-775. PubMed ID: 23972508
[TBL] [Abstract][Full Text] [Related]
2. Juvenile xanthogranuloma and nevus anemicus in the diagnosis of neurofibromatosis type 1.
Ferrari F; Masurel A; Olivier-Faivre L; Vabres P
JAMA Dermatol; 2014 Jan; 150(1):42-6. PubMed ID: 24258576
[TBL] [Abstract][Full Text] [Related]
3. Nevus anemicus: a distinctive cutaneous finding in neurofibromatosis type 1.
Hernández-Martín A; García-Martínez FJ; Duat A; López-Martín I; Noguera-Morel L; Torrelo A
Pediatr Dermatol; 2015; 32(3):342-7. PubMed ID: 25690591
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous Manifestations not Considered Diagnostic Criteria for Neurofibromatosis Type 1. A Case-Control Study.
García-Martínez FJ; Duat-Rodríguez A; Andrés Esteban E; Torrelo A; Noguera Morel L; Hernández-Martín A
Actas Dermosifiliogr; 2022; 113(10):T923-T929. PubMed ID: 36162491
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous Manifestations not Considered Diagnostic Criteria for Neurofibromatosis Type 1. A Case-Control Study.
García-Martínez FJ; Duat-Rodríguez A; Andrés Esteban E; Torrelo A; Noguera Morel L; Hernández-Martín A
Actas Dermosifiliogr; 2022; 113(10):923-929. PubMed ID: 35636506
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of café au lait macules at initial consultation in the diagnosis of neurofibromatosis type 1.
Nunley KS; Gao F; Albers AC; Bayliss SJ; Gutmann DH
Arch Dermatol; 2009 Aug; 145(8):883-7. PubMed ID: 19687418
[TBL] [Abstract][Full Text] [Related]
7. Predicting neurofibromatosis type 1 risk among children with isolated café-au-lait macules.
Ben-Shachar S; Dubov T; Toledano-Alhadef H; Mashiah J; Sprecher E; Constantini S; Leshno M; Messiaen LM
J Am Acad Dermatol; 2017 Jun; 76(6):1077-1083.e3. PubMed ID: 28318682
[TBL] [Abstract][Full Text] [Related]
8. Genetic analyses of mosaic neurofibromatosis type 1 with giant café-au-lait macule, plexiform neurofibroma and multiple melanocytic nevi.
Hida T; Idogawa M; Okura M; Sugita S; Sugawara T; Sasaki Y; Tokino T; Yamashita T; Uhara H
J Dermatol; 2020 Jun; 47(6):658-662. PubMed ID: 32246533
[TBL] [Abstract][Full Text] [Related]
9. Neurofibromatosis Type 1: Diagnostic Timelines in Children.
García-Martínez FJ; Hernández-Martín A
Actas Dermosifiliogr; 2023 Mar; 114(3):187-193. PubMed ID: 36370836
[TBL] [Abstract][Full Text] [Related]
10. Café-au-lait Macules and Neurofibromatosis Type 1: A Review of the Literature.
Bernier A; Larbrisseau A; Perreault S
Pediatr Neurol; 2016 Jul; 60():24-29.e1. PubMed ID: 27212418
[TBL] [Abstract][Full Text] [Related]
11. An Update on Neurofibromatosis Type 1: Not Just Café-au-Lait Spots and Freckling. Part II. Other Skin Manifestations Characteristic of NF1. NF1 and Cancer.
Hernández-Martín A; Duat-Rodríguez A
Actas Dermosifiliogr; 2016; 107(6):465-73. PubMed ID: 26956402
[TBL] [Abstract][Full Text] [Related]
12. Value of a café-au-lait macules screening clinic: Experience from The Hospital for Sick Children in Toronto.
Albaghdadi M; Berseneva M; Pennal A; Wan S; Matviychuk D; Shugar A; Kannu P; Lara-Corrales I
Pediatr Dermatol; 2022 Mar; 39(2):205-210. PubMed ID: 35178768
[TBL] [Abstract][Full Text] [Related]
13. Nevus Anemicus As an Additional Diagnostic Marker of Neurofibromatosis Type 1 in Childhood.
Vaassen P; Rosenbaum T
Neuropediatrics; 2016 Jun; 47(3):190-3. PubMed ID: 27019377
[TBL] [Abstract][Full Text] [Related]
14. Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome.
Messiaen L; Yao S; Brems H; Callens T; Sathienkijkanchai A; Denayer E; Spencer E; Arn P; Babovic-Vuksanovic D; Bay C; Bobele G; Cohen BH; Escobar L; Eunpu D; Grebe T; Greenstein R; Hachen R; Irons M; Kronn D; Lemire E; Leppig K; Lim C; McDonald M; Narayanan V; Pearn A; Pedersen R; Powell B; Shapiro LR; Skidmore D; Tegay D; Thiese H; Zackai EH; Vijzelaar R; Taniguchi K; Ayada T; Okamoto F; Yoshimura A; Parret A; Korf B; Legius E
JAMA; 2009 Nov; 302(19):2111-8. PubMed ID: 19920235
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous manifestations in neurofibromatosis type 1.
Miraglia E; Moliterni E; Iacovino C; Roberti V; Laghi A; Moramarco A; Giustini S
Clin Ter; 2020; 171(5):e371-e377. PubMed ID: 32901776
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of multiple café-au-lait macules for neurofibromatosis 1 in Chinese children.
Yao R; Wang L; Yu Y; Wang J; Shen Y
J Dermatol; 2016 May; 43(5):537-42. PubMed ID: 26458495
[TBL] [Abstract][Full Text] [Related]
17. Nevus anemicus associated with neurofibromatosis type 1 in a neonate: a case report.
Cerini C; Pogliani L; Mameli C; Zuccotti GV
G Ital Dermatol Venereol; 2015 Dec; 150(6):745-7. PubMed ID: 26513044
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous and Systemic Findings in Mosaic Neurofibromatosis Type 1.
Vázquez-Osorio I; Duat-Rodríguez A; García-Martínez FJ; Torrelo A; Noguera-Morel L; Hernández-Martín A
Pediatr Dermatol; 2017 May; 34(3):271-276. PubMed ID: 28318056
[TBL] [Abstract][Full Text] [Related]
19. Juvenile xanthogranuloma associated with neurofibromatosis 1: 14 patients without evidence of hematologic malignancies.
Cambiaghi S; Restano L; Caputo R
Pediatr Dermatol; 2004; 21(2):97-101. PubMed ID: 15078345
[TBL] [Abstract][Full Text] [Related]
20. Updated Approach to Patients with Multiple Café au Lait Macules.
Albaghdadi M; Thibodeau ML; Lara-Corrales I
Dermatol Clin; 2022 Jan; 40(1):9-23. PubMed ID: 34799039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
